U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H15NO3
Molecular Weight 149.1882
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TROLAMINE

SMILES

OCCN(CCO)CCO

InChI

InChIKey=GSEJCLTVZPLZKY-UHFFFAOYSA-N
InChI=1S/C6H15NO3/c8-4-1-7(2-5-9)3-6-10/h8-10H,1-6H2

HIDE SMILES / InChI

Molecular Formula C6H15NO3
Molecular Weight 149.1882
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created using several sources including: http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/11340s16lbl.pdf; https://www.ons.org/intervention/trolamine-biafine®; https://www.ncbi.nlm.nih.gov/pubmed/?term=15084618; https://clinicaltrials.gov/ct2/show/NCT02729324; http://www.ncbi.nlm.nih.gov/pubmed/18441842

Trolamine, an organic compound, is the salt formed between triethanolamine and salicylic acid. It is widely used as a topical analgesic. 10% trolamine salicylate medical products sold over-the-counter such as are creams for temporarily relief of minor aches and pains of muscles and joints associated with arthritis, simple backache, lumbago, neuralgia, strains, bruises, and sprains. The FDA approved in 1958 otic solution drops containing triethanolamine polypeptide used in the ear to break down and loosen earwax was discontinued. Trolamine can enhance skin healing by recruiting macrophages and modifying the concentrations of various immunomodulators. Trolamine (Biafine; Genmedix Ltd, France) is commonly prescribed at the beginning of radiotherapy for preventing acute radiation-induced skin toxicity in China. Biafine has been studied in radiodermatitis and Phase 2 clinical trial has been initiated in 2016 by Sun Yat-sen University to establish the efficacy of trolamine (Biafine) for the management of radiation dermatitis in patients with nasopharyngeal carcinoma receiving IMRT.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
Volu-Firm

Approved Use

Unknown
Palliative
CERUMENEX

Approved Use

For removal of impacted cerumen prior to ear examination, otologic therapy and/or audiometry. CERUMENEX Eardrops should be used only with caution in external otitis.

Launch Date

1958
Doses

Doses

DosePopulationAdverse events​
5.38 mg 2 times / day multiple, topical
Studied dose
Dose: 5.38 mg, 2 times / day
Route: topical
Route: multiple
Dose: 5.38 mg, 2 times / day
Sources:
unhealthy, 21.6–84.9
n = 15
Health Status: unhealthy
Condition: Wound
Age Group: 21.6–84.9
Sex: M+F
Population Size: 15
Sources:
Disc. AE: Application site erythema...
AEs leading to
discontinuation/dose reduction:
Application site erythema (6.7%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Application site erythema 6.7%
Disc. AE
5.38 mg 2 times / day multiple, topical
Studied dose
Dose: 5.38 mg, 2 times / day
Route: topical
Route: multiple
Dose: 5.38 mg, 2 times / day
Sources:
unhealthy, 21.6–84.9
n = 15
Health Status: unhealthy
Condition: Wound
Age Group: 21.6–84.9
Sex: M+F
Population Size: 15
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Preliminary assessment of selected methacrylic acid--acrylic acid copolymers as factors buffering triethanolamine interacting with artificial skin sebum.
2001
[Enantiomeric separation of drugs with capillary electrophoresis with cyclodextrins].
2001
Fluorescent derivatization of nitrite ions with 2,3-diaminonaphthalene utilizing a pH gradient in a Y-shaped microchannel.
2001 Apr
In vitro percutaneous absorption of tenoxicam from pressure-sensitive adhesive matrices across the hairless mouse skin.
2001 Dec
Vanadium, molybdenum, and sodium triethanolamine complexes derived from an assembly system containing tetrathiometalate and triethanolamine.
2001 Jul 16
Luminol chemiluminescence in unbuffered solutions with a cobalt(II)-ethanolamine complex immobilized on resin as catalyst and its application to analysis.
2001 Nov 1
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
2002 Apr 2
Analysis of illicit amphetamine seizures by capillary zone electrophoresis.
2002 Dec 6
Enantiomeric separation of TAPP, H-Tyr-(D)Ala-Phe-Phe-NH(2), by capillary electrophoresis using 18-crown-6-tetracarboxylic acid as a chiral selector.
2003 Aug 15
Dynamic localization of SPE-9 in sperm: a protein required for sperm-oocyte interactions in Caenorhabditis elegans.
2003 Dec 3
Correlation between pK(a) and reactivity of quinuclidine-based catalysts in the Baylis-Hillman reaction: discovery of quinuclidine as optimum catalyst leading to substantial enhancement of scope.
2003 Feb 7
Capillary electrophoresis determinations of trace concentrations of inorganic ions in large excess of chloride: soft modelling using artificial neural networks for optimisation of electrolyte composition.
2003 Jun
Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum.
2003 Mar
Synthesis of uniform anatase TiO2 nanoparticles by gel-sol method. 4. Shape control.
2003 Mar 1
Substantial increase of the ordering temperature for [MnII/MoIII(CN)7]-based magnets as a function of the 3d ion site geometry: example of two supramolecular materials with Tc = 75 and 106 K.
2003 Mar 10
Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography.
2003 May-Jun
Reactivity with Tris(hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins.
2003 Oct
Carbopols as factors buffering triethanolamine interacting with artificial skin sebum.
2004
Effect of some anionic polymers on pH of triethanolamine aqueous solutions.
2004
Evaluation of method of preparation of passive diffusion tubes for measurement of ambient nitrogen dioxide.
2004 Jan
Mechanical and water barrier properties of glutenin films influenced by storage time.
2004 Jan 14
Quantitation of biomarkers of exposure to nitrogen mustards in urine from rats dosed with nitrogen mustards and from an unexposed human population.
2004 Jul-Aug
Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice.
2004 Jun
Alternative approach to enhancing cation selectivity in ion chromatography.
2004 Jun 11
Titanatranes derailed: static and dynamic triethanolamine slippage induced by polyphenoxide chelation.
2004 Nov 1
Efficient photocurrent generation by self-assembled monolayers composed of 3 10-helical peptides carrying linearly spaced naphthyl groups at the side chains.
2004 Oct 13
Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG).
2004 Sep
Co phytoavailability for tomato in amended calcareous soils.
2005 Apr
Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography.
2005 Feb 14
Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes.
2005 Jan 21
Generation of human antibody fragments against Streptococcus mutans using a phage display chain shuffling approach.
2005 Jan 25
New structural motifs in manganese single-molecule magnetism from the use of triethanolamine ligands.
2005 Jan 28
Ion chromatographic analysis of amines, alkanolamines, and associated anions in concrete.
2005 Mar
A factor analysis for complex systems containing nimesulide.
2005 Mar
Photoreduction behavior of cytochrome c by zinc porphyrin in lipid media.
2005 May 13
Effect of cationic micellar aggregates on the kinetics of oxidation of aminoalcohols by N-bromosuccinimide in alkaline medium.
2005 May 15
Patents

Sample Use Guides

Fill ear canal with ear drops of 10% triethanolamine Polypeptide Oleate-Condensate with the patient’s head tilted at a 45° angle. Insert cotton plug and allow to remain 15-30 minutes. Then gently flush with lukewarm water, using a soft rubber syringe (avoid excessive pressure). Exposure of skin outside the ear to the drug should be avoided. The procedure may be repeated if the first application fails to clear the impaction.
Route of Administration: Otic (auricular)
Penetration of triethanolamine into artificial skin sebum and its uplift were measured using 0.1 M aqueous triethanolamine solution.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:03:16 GMT 2023
Edited
by admin
on Fri Dec 15 16:03:16 GMT 2023
Record UNII
9O3K93S3TK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TROLAMINE
EP   HSDB   II   INN   MART.   USP-RS   VANDF   WHO-DD  
INN  
Official Name English
TROLAMINE [MART.]
Common Name English
TROLAMINE [EP MONOGRAPH]
Common Name English
TRIETHANOLAMINE [VANDF]
Common Name English
TROLAMINE [II]
Common Name English
TROLAMINE [HSDB]
Common Name English
TRIETHANOLAMINE [INCI]
Common Name English
ETHANOL, 2,2',2''-NITRILOTRIS-
Systematic Name English
TROLAMINE [EP IMPURITY]
Common Name English
NSC-36718
Code English
Trolamine [WHO-DD]
Common Name English
TRIETHANOLAMINE [IARC]
Common Name English
TROLAMINE [VANDF]
Common Name English
TRIETHANOLAMINE [MI]
Common Name English
TRIETHANOLAMINE
INCI   MI   VANDF  
INCI  
Official Name English
trolamine [INN]
Common Name English
2,2',2''-NITRILOTRIETHANOL
Systematic Name English
Classification Tree Code System Code
WHO-ATC D03AX12
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
EPA PESTICIDE CODE 4208
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
Code System Code Type Description
DRUG CENTRAL
2768
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
ChEMBL
CHEMBL446061
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
MERCK INDEX
m11100
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY Merck Index
WIKIPEDIA
TRIETHANOLAMINE
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
ECHA (EC/EINECS)
203-049-8
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
INN
561
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
CHEBI
28621
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
CONCEPT Industrial Aid
EVMPD
SUB12376MIG
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
FDA UNII
9O3K93S3TK
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID9021392
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
RS_ITEM_NUM
1696958
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
RXCUI
38623
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY RxNorm
DRUG BANK
DB13747
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
SMS_ID
100000079034
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NSC
36718
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
DAILYMED
9O3K93S3TK
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
MESH
C009546
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
PUBCHEM
7618
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
NCI_THESAURUS
C80948
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
CAS
102-71-6
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
HSDB
893
Created by admin on Fri Dec 15 16:03:16 GMT 2023 , Edited by admin on Fri Dec 15 16:03:16 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (GC)
EP
Related Record Type Details
ACTIVE MOIETY